retatrutide phase 2 trial weight loss of for Obesity Retatrutide Results After 40: Realistic
Description
Zepbound is not recommended during pregnancy or breastfeeding
Currently, there is no established causal link between tirzepatide use and increased risk of blood clots (venous thromboembolism or arterial thrombosis) based on available clinical trial data and post-marketing surveillance
National Library of Medicine : Semaglutide (Wegovy): CADTH Reimbursement Review: Therapeutic area: Weight management [Internet]
How Do GLP-1 Medications Help with Weight Loss
doi.org/10.1001/jamaophthalmol.2024.6058
Tirzepatide is sold under the brand name Mounjaro, which is also approved only to treat type 2 diabetes
